| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e067dc85f47e4d9c97a4f9caf2aac0f8 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
| filingDate |
2003-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61dfbf76ffb52d29d21cfa5a4e24761c |
| publicationDate |
2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2004269364-A |
| titleOfInvention |
Anticancer agent having DNA homologous recombination repair inhibitory activity |
| abstract |
An object of the present invention is to inhibit repair of DNA homologous recombination among two pathways in repair of DNA double-strand breaks. A DNA homologous recombination repair inhibitor comprising withaferrin A or a derivative thereof as an active ingredient. [Selection diagram] Fig. 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017201978-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005082392-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4868403-B2 |
| priorityDate |
2003-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |